SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · EVP sells $1.97M in shares

TEVA PHARMACEUTICAL INDUSTRIES LTD · 144 filed Nov 12, 2026 at 16:00 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 12, 2026 at 16:00 ET

Mark Sabag, EVP of International Markets Commercial at Teva, filed a Form 144 notice of intent to sell 44,710 ordinary shares valued at approximately $1.97M. The sale is tied to a stock option exercise and represents a routine insider transaction for compensation purposes.

  • Mark Sabag (EVP International Markets Commercial) filed Form 144 to sell 44,710 ordinary shares
  • Estimated aggregate value of the proposed sale is $1,973,545.81
  • Sale is related to a stock option exercise and compensation
  • Broker for the sale is Citigroup Global Markets Inc.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access